SCFAs also increase insulin levels (via GSIS) independent of blood glucose concentrations, and increase muscular and systemic insulin sensitivity, and obesity-related reductions in SCFAs promote peripheral insulin resistance and consequently hyperinsulinemia [101]. The gene discussed is INS; the disease is Hyperinsulinemia.